Literature DB >> 23635855

Long-term outcomes of penetrating keratoplasty and Descemet stripping endothelial keratoplasty for Fuchs endothelial dystrophy: fellow eye comparison.

Mustafa Kosker1, Kunal Suri, Fulya Duman, Kristin M Hammersmith, Parveen K Nagra, Christopher J Rapuano.   

Abstract

PURPOSE: To compare the visual outcomes and complications after Descemet stripping endothelial keratoplasty (DSEK) and penetrating keratoplasty (PK) in the same set of patients.
METHODS: Fifteen patients underwent PK in 1 eye and DSEK in the fellow eye for Fuchs endothelial dystrophy at the Wills Eye Institute from 1993 to 2011.
RESULTS: Mean postoperative best-corrected visual acuity in the PK and DSEK groups (0.39 ± 0.39 and 0.23 ± 0.12 logarithm of the minimum angle of resolution, respectively) was statistically significantly better than mean preoperative best-corrected visual acuity (0.83 ± 0.36 and 0.76 ± 0.34 logarithm of the minimum angle of resolution, respectively) (P < 0.025 and P < 0.001, respectively). Mean manifest refraction cylinder was higher in the PK eyes than in the DSEK eyes at 1 year [3.58 ± 1.82 and 1.23 ± 1.63 diopter (D), respectively] and at 2 years of follow-up (3.57 ± 1.81 and 1.05 ± 1.18 D, respectively) (P < 0.001) but was not statistically different at the last visit (3.18 ± 2.67 and 1.5 ± 1.66 D, respectively) (P = 0.052). Mean postoperative follow-up was 101.9 ± 39.5 and 29.9 ± 19.9 months after PK and DSEK, respectively. Most common complications after PK were high astigmatism in 15 eyes, monocular diplopia in 7 eyes, posterior capsule opacity in 6 eyes, and secondary glaucoma and graft rejection episodes in 5 eyes each. After DSEK, secondary glaucoma in 3 eyes and graft rejection in 2 eyes were the most common complications.
CONCLUSIONS: Final visual outcomes were not statistically different between the 2 procedures, but DSEK had early visual stabilization and PK had a more complicated course, with more astigmatism, rejections, suture-related infections, and graft failures.

Entities:  

Mesh:

Year:  2013        PMID: 23635855     DOI: 10.1097/ICO.0b013e31828ea02a

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

1.  [Perforating keratoplasty versus Descemet stripping automated endothelial keratoplasty in the partner eye: Functional results and patient satisfaction].

Authors:  N J Gross; D Böhringer; P Maier; T Reinhard
Journal:  Ophthalmologe       Date:  2015-10       Impact factor: 1.059

2.  Comparison of graft survival following penetrating keratoplasty and Descemet's stripping endothelial keratoplasty in eyes with a glaucoma drainage device.

Authors:  Shawn M Iverson; Oriel Spierer; George C Papachristou; William J Feuer; Wei Shi; David S Greenfield; Terrence P O'Brien
Journal:  Int Ophthalmol       Date:  2017-03-16       Impact factor: 2.031

3.  A 5-year analysis of endothelial vs penetrating keratoplasty graft survival in Chinese patients.

Authors:  Anita Lai Wah Li; Rachel Pui Wai Kwok; Ka Wai Kam; Alvin Lerrmann Young
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

4.  Visual outcome of penetrating keratoplasty, deep anterior lamellar keratoplasty and Descemet membrane endothelial keratoplasty.

Authors:  Clàudia Garrido; Genís Cardona; Josep L Güell; Jaume Pujol
Journal:  J Optom       Date:  2017-11-13

Review 5.  Challenges in the complex management of post-keratoplasty glaucoma.

Authors:  Lisa-Marie Anders; Zisis Gatzioufas; Matthias C Grieshaber
Journal:  Ther Adv Ophthalmol       Date:  2021-07-20

6.  Efficacy of Lamellar Keratoplasty with Acellular Porcine Corneal Stroma in Treatment for Infectious Central and Peripheral Corneal Ulcers.

Authors:  Yingxin Chen; Linlin Zhang; Zhiling Liu; Qiming Liu; Minghong Gao
Journal:  Ther Clin Risk Manag       Date:  2021-06-10       Impact factor: 2.423

7.  Comparative observation of the efficacy of simplified Descemet stripping endothelial keratoplasty and penetrating keratoplasty in treating bullous keratopathy.

Authors:  Yingxin Chen; Shanshan Sun; Minghong Gao; Qiming Liu; Ziyue Wang
Journal:  Exp Ther Med       Date:  2020-09-01       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.